Cell-Type-Specific Translation Profiling Reveals a Novel Strategy for Treating Fragile X Syndrome
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Excessive mRNA translation downstream of group I metabotropic glutamate receptors (mGlu 1/5 ) is a core pathophysiology of fragile X syndrome (FX); however, the differentially translating mRNAs that contribute to altered neural function are not known.We used translating ribosome affinity purification (TRAP) and RNA-seq to identify mistranslating mRNAs in CA1 pyramidal neurons of the FX mouse model (Fmr1 À/y ) hippocampus, which exhibit exaggerated mGlu 1/5 -induced long-term synaptic depression (LTD).In these neurons, we find that the Chrm4 transcript encoding muscarinic acetylcholine receptor 4 (M 4 ) is excessively translated, and synthesis of M 4 downstream of mGlu 5 activation is mimicked and occluded.Surprisingly, enhancement rather than inhibition of M 4 activity normalizes core phenotypes in the Fmr1 À/y , including excessive protein synthesis, exaggerated mGluR-LTD, and audiogenic seizures.These results suggest that not all excessively translated mRNAs in the Fmr1 À/y brain are detrimental, and some may be candidates for enhancement to correct pathological changes in the FX brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
Salmon provides fast and bias-aware quantification of transcript expression
Patro, R., Duggal, G., Love, M. I., Irizarry, R. A., & Kingsford, C. (2017) · Nature Methods · doi:10.1038/nmeth.4197 · Cited by 12,700
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Chen, E. Y., Tan, C. M., Kou, Y., Duan, Q., Wang, Z., Meirelles, G. V., Clark, N. R., & Ma’ayan, A. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-128 · Cited by 7,814
The Pfam protein families database: towards a more sustainable future
Finn, R. D., Coggill, P., Eberhardt, R. Y., Eddy, S. R., Mistry, J., Mitchell, A. L., Potter, S. C., Punta, M., Qureshi, M., Sangrador-Vegas, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1344 · Cited by 5,975
FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072 · cited 6×
“Although there have been excellent studies identifying FMRP target mRNAs (Brown et al., 2001; Darnell et al., 2011), as well as proteins differentially expressed in the Fmr1 /y brain (Klemmer et al., 2011; Liao et al., 2008; Tang et al., 2015), there is little known about the identities of the…”
BackgroundResultInfluentialThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 3×
“Publi This is an open access article under the CC BY license (http://creative FMRP is synthesized at synapses by activation of group I metabotropic glutamate receptors (mGlu1/5), where it acts as a negative regulator of the mRNA translation supporting long-term synaptic depression (LTD) (Bear et al., 2004; Weiler et a…”
BackgroundAltered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 5×
“Isolation of Translating mRNAs from Hippocampal CA1 Pyramidal Neurons Using TRAP InFmr1 CA1, excessive translation contributes to the exaggeration of mGluR-LTD (Huber et al., 2002).”
BackgroundMethodResultInfluentialA translational profiling approach for the molecular characterization of CNS cell types
Heiman, M., Schaefer, A., Gong, S., Peterson, J. D., Day, M., Ramsey, K. E., Suárez-Fariñas, M., Schwarz, C., Stephan, D. A., Surmeier, D. J., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.028 · Cited by 1,134 · cited 7×
“Although the TRAP method was developed to identify differences in the expression of mRNAs in select neuronal populations, with no distinction between changes driven by translation or transcription (Doyle et al., 2008; Heiman et al., 2008), we used this approach to investigate the increased translation that is a well-k…”
BackgroundMethodInfluentialBrown, V., Jin, P., Ceman, S., Darnell, J. C., O'Donnell, W. T., Tenenbaum, S. A., Jin, X., Feng, Y., Wilkinson, K. D., Keene, J. D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00568-2 · Cited by 1,109 · cited 2×
“Although there have been excellent studies identifying FMRP target mRNAs (Brown et al., 2001; Darnell et al., 2011), as well as proteins differentially expressed in the Fmr1 /y brain (Klemmer et al., 2011; Liao et al., 2008; Tang et al., 2015), there is little known about the identities of the…”
BackgroundFragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051 · cited 1×
“M4 Is Translated Downstream of mGlu5 Activation Protein synthesis downstream of mGlu1/5 is elevated in the Fmr1 /y brain, and this occludes further translation (Bassell and Warren, 2008; Osterweil et al., 2010).”
BackgroundCorrection of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · cited 1×
“Excessive protein synthesis has been observed in multiple brain regions of the Fmr1 /y mouse (Dölen et al., 2007; Osterweil et al., 2010; Qin et al., 2005), and several strategies that reduce protein synthesis have been shown to correct pathological phenotypes (Bhattacharya et al., 2016; Gross et…”
BackgroundSelf-citationMeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system
Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S., & Heintz, N. (2012) · Cell · doi:10.1016/j.cell.2012.11.022 · Cited by 943
Application of a translational profiling approach for the comparative analysis of CNS cell types
Doyle, J. P., Dougherty, J. D., Heiman, M., Schmidt, E. F., Stevens, T. R., Ma, G., Bupp, S., Shrestha, P., Shah, R. D., Doughty, M. L., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.029 · Cited by 912 · cited 3×
“For our study, we used a BAC transgenic line that shows a CA1 pyramidal-specific expression ofGFP-L10awithin the hippocampus (referred to as CA1-TRAP) (Doyle et al., 2008; Tao et al., 2016).”
MethodZalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676 · cited 1×
“In order to confirm that changes seen in Fmr1 /y TRAP-bound mRNAs are consistent with changes seen using other methodologies, we measured the expression of Camk2a, previously shown to be over-translated in multiple studies (Darnell et al., 2011; Osterweil et al., 2010; Zalfa et al., 2003).”
ResultWeiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644 · cited 2×
“Publi This is an open access article under the CC BY license (http://creative FMRP is synthesized at synapses by activation of group I metabotropic glutamate receptors (mGlu1/5), where it acts as a negative regulator of the mRNA translation supporting long-term synaptic depression (LTD) (Bear et al., 2004; Weiler et a…”
BackgroundThe Autistic Neuron: Troubled Translation?
Kelleher, R. J., & Bear, M. F. (2008) · Cell · doi:10.1016/j.cell.2008.10.017 · Cited by 598
Feng, Y., Gutekunst, C.-A., Eberhart, D. E., Yi, H., Warren, S. T., & Hersch, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01539.1997 · Cited by 532 · cited 1×
“It is also possible that loss of FMRP disrupts RNA transport and/or stability (Feng et al., 1997; Tamanini et al., 1999; Zalfa et al., 2007).”
BackgroundSuppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.06.004 · Cited by 521 · cited 3×
“One of the most robust behavioral phenotypes observed in the Fmr1 mousemodel is an increased susceptibility for AGS (Yan et al., 2005).”
BackgroundChronic Pharmacological mGlu5 Inhibition Corrects Fragile X in Adult Mice
Michalon, A., Sidorov, M., Ballard, T. M., Ozmen, L., Spooren, W., Wettstein, J. G., Jaeschke, G., Bear, M. F., & Lindemann, L. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.009 · Cited by 489
Waung, M. W., Pfeiffer, B. E., Nosyreva, E. D., Ronesi, J. A., & Huber, K. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.05.014 · Cited by 474 · cited 1×
“To ensure that our assay accurately reflected mGlu1/5-stimulated translation, we quantified the levels of mRNA encoding the cytoskeletal plasticity protein Arc, which is translated in response to DHPG stimulation and induction of LTD in hippocampal CA1 (Waung et al., 2008).”
MethodMuscarinic acetylcholine receptors: novel opportunities for drug development
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4295 · Cited by 437
Muddashetty, R. S., Kelić, S., Gross, C., Xu, M., & Bassell, G. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0937-07.2007 · Cited by 421
Osterweil, E. K., Krueger, D. D., Reinhold, K., & Bear, M. F. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3888-10.2010 · Cited by 384 · cited 14×
“To test for AGS, we habituated animals to the testing arena and then exposed them to a loud (>120 dB) alarm for 2 min (see STAR Methods; Figure 7A).”
BackgroundMethodResultInfluentialSelf-citationQin, M., Kang, J., Burlin, T. V., Jiang, C., & Smith, C. B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0093-05.2005 · Cited by 263
Henderson, C., Wijetunge, L., Kinoshita, M. N., Shumway, M., Hammond, R. S., Postma, F. R., Brynczka, C., Rush, R., Thomas, A., Paylor, R., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004218 · Cited by 249 · cited 2×
“…et al., 2007; Osterweil et al., 2010; Qin et al., 2005), and several strategies that reduce protein synthesis have been shown to correct pathological phenotypes (Bhattacharya et al., 2016; Gross et al., 2015; Henderson et al., 2012; Liu et al., 2012; Michalon et al., 2012; Osterweil et al., 2013).”
BackgroundSelf-citationOsterweil, E. K., Chuang, S.-C., Chubykin, A. A., Sidorov, M., Bianchi, R., Wong, R. K. S., & Bear, M. F. (2013) · Neuron · doi:10.1016/j.neuron.2012.01.034 · Cited by 230 · cited 3×
“Several other strategies that acutely reduce protein synthesis have also been shown to correct LTD in the Fmr1 /y, includingmGlu5 antagonist, lovastatin, and lithium (Choi et al., 2011; Michalon et al., 2012; Osterweil et al., 2013).”
BackgroundSelf-citationGross, C., Chang, C.-W., Kelly, S. M., Bhattacharya, A., McBride, S. M. J., Danielson, S. W., Jiang, M. Q., Chan, C. B., Ye, K., Gibson, J. R., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.060 · Cited by 117
Convergence of Hippocampal Pathophysiology in Syngap +/− and Fmr1 −/ y Mice
Barnes, S. A., Wijetunge, L. S., Jackson, A. D., Katsanevaki, D., Osterweil, E. K., Komiyama, N. H., Grant, S. G. N., Bear, M. F., Nägerl, U. V., Kind, P. C., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1087-15.2015 · Cited by 84
Self-citationCyclic AMP metabolism in fragile X syndrome
Berry‐Kravis, E., & Huttenlocher, P. R. (1992) · Annals of Neurology · doi:10.1002/ana.410310105 · Cited by 81 · cited 1×
“558 Neuron 95, 550–563, August 2, 2017 In addition to exaggerated protein synthesis, a prominent cellular change observed in the Fmr1 /y is a reduced production of cAMP upon stimulation of adenylate cyclase (AC) (Berry-Kravis et al., 1995; Berry-Kravis and Huttenlocher, 1992; Kelley et al., 2007).”
BackgroundBhattacharya, A., Mamcarz, M., Mullins, C., Choudhury, A., Boyle, R. G., Smith, D. G., Walker, D. W., & Klann, E. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.369 · Cited by 51 · cited 2×
“…et al., 2007; Osterweil et al., 2010; Qin et al., 2005), and several strategies that reduce protein synthesis have been shown to correct pathological phenotypes (Bhattacharya et al., 2016; Gross et al., 2015; Henderson et al., 2012; Liu et al., 2012; Michalon et al., 2012; Osterweil et al., 2013).”
BackgroundChoi, C. H., Schoenfeld, B. P., Bell, A. J., Hinchey, J., Rosenfelt, C., Gertner, M. J., Campbell, S. R., Emerson, D., Hinchey, P., Kollaros, M., et al. (2016) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2016.00136 · Cited by 46 · cited 1×
“558 Neuron 95, 550–563, August 2, 2017 of this phenotype to the pathology of FX is confirmed by experiments that show that increasing cAMP production corrects several behavioral measures of learning inmultiple animal models (Choi et al., 2015, 2016).”
Background
Cited by
Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography
Andersson, A., Bergenstråhle, J., Asp, M., Bergenstråhle, L., Jurek, A., Fernández Navarro, J., & Lundeberg, J. (2020) · Communications Biology · doi:10.1038/s42003-020-01247-y · Cited by 457
The molecular biology of FMRP: new insights into fragile X syndrome
Richter, J. D., & Zhao, X. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00432-0 · Cited by 390
Bassoon proteinopathy drives neurodegeneration in multiple sclerosis
Schattling, B., Engler, J. B., Volkmann, C., Rothammer, N., Woo, M. S., Petersen, M., Winkler, I., Kaufmann, M., Rosenkranz, S. C., Fejtova, A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0385-4 · Cited by 86
Asiminas, A., Jackson, A. D., Louros, S. R., Till, S. M., Spano, T., Dando, O., Bear, M. F., Chattarji, S., Hardingham, G. E., Osterweil, E. K., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aao0498 · Cited by 78
Self-citationLovastatin, Not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model
Muscas, M., Louros, S. R., & Osterweil, E. K. (2019) · eneuro · doi:10.1523/eneuro.0097-19.2019 · Cited by 30
Self-citation
Metadata
- Authors
- Thomson, S. R., Seo, S. S., Barnes, S. A., Louros, S. R., Muscas, M., Dando, O., Kirby, C., Wyllie, D. J. A., Hardingham, G. E., Kind, P. C., & Osterweil, E. K.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 95
- Issue
- 3
- Pages
- 550-563.e5
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2744596343
- Cited by
- 104
- References
- 31
- FWCI
- 6.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.